Adult stem or progenitor cells in treatment for type 1 diabetes: current progress
Since the development of the Edmonton Islet Transplantation Protocol, islet transplantation has given new hope to patients with type 1 diabetes. Like solid organ transplantation, one of the biggest challenges islet transplantation faces is the shortage of available donor tissue. Finding an alternative source of islet tissue has become an increasingly important field of study. The possibility of generating insulin-secreting cells and islet tissue with adult pancreatic stem or progenitor cells has been investigated extensively. This review aims to discuss recent progress in the study of adult pancreatic stem or progenitor cells and to suggest future directions in this field.
ABSTRACTBackground: Although it is generally presumed that experienced clinicians are capable of making reasonable decisions concerning rehabilitation potential, inexperienced clinicians may expend efforts and resources somewhat unproductively in managing patients with nonprogressive neurological conditions such as stroke. Clinicians with varied experience may also be influenced by extraneous factors least likely to contribute to an effective admission and treatment planning. Purpose: We report a process for efficient utilization of resources to maximize outcome following stroke rehabilitation. Description: A care planning process with distinctive features of patient profiling, treatment tracking, and outcome staircasing was developed and utilized in the subacute stroke management of African American stroke survivors in an inpatient facility in New York. Outcome of stroke rehabilitation care were compared before and after the implementation of the process using Functional Independence Measures (FIM) score...